Study wrapper · #205
Metabolism of growth hormone releasing peptides.
Editor's note
A metabolism study serving anti-doping detection, using rats and human-serum in-vitro models — not a study of clinical effect. To fill gaps in knowledge of how these compounds break down, researchers characterised the urinary metabolites of eight GHRPs, including ipamorelin and hexarelin, after oral and intravenous dosing in rats, then confirmed the main metabolites using human serum and a recombinant amidase. They identified 28 metabolites (at least three per peptide), all formed by enzymatic cleavage. The value is analytical: knowing which breakdown fragments to look for improves doping tests. Frame this as preclinical and forensic; the human in-vitro confirmation strengthens the detection relevance but does not extend to efficacy, safety, or dosing in people. It tells us how the body enzymatically processes these peptides, which is mechanistically interesting, but says nothing about whether they benefit any condition. Human clinical data would be needed for any such conclusion.
Plain-language abstract
This study mapped how the body breaks down a family of growth-hormone-releasing peptides — including ipamorelin and hexarelin — so that anti-doping labs know which breakdown products to search for. Most of these peptides are not approved medicines but are easily bought online, and until this work their metabolism was largely unknown. Researchers gave the peptides to rats, both by mouth and by injection, and collected urine. They also tested how the peptides break apart in human blood serum and with a purified human enzyme. Using sensitive, high-accuracy mass spectrometry, they identified 28 breakdown products — at least three for each peptide — all created when enzymes snip the peptides at different points. The main rat breakdown products were confirmed in the human serum model, making them useful detection markers. This is a detection-focused metabolism study: it explains how these peptides are chemically processed, but it does not test whether they help any health condition or cause side effects, and human data would be needed to draw any such conclusions.